12 Months Persistent Immunogenicity after Hepatitis B Vaccination in Patients with Type 2 Diabetes and Immunogenicity of Revaccination in Non-Responders: An Open-Label Randomized Controlled Trial.
Saved in:
| Title: | 12 Months Persistent Immunogenicity after Hepatitis B Vaccination in Patients with Type 2 Diabetes and Immunogenicity of Revaccination in Non-Responders: An Open-Label Randomized Controlled Trial. |
|---|---|
| Authors: | Han B; Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China., Liu W; Jingyuan County Center for Disease Control and Prevention, Baiyin 730600, China., Du J; Department of Laboratorial Science and Technology & Vaccine Research Center, School of Public Health, Peking University, Beijing 100191, China., Liu H; Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China., Zhao T; Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China., Yang S; Jingyuan County Center for Disease Control and Prevention, Baiyin 730600, China., Wang S; Department of Infectious Diseases and Clinical Microbiology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China., Zhang S; Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China., Liu B; Department of Laboratorial Science and Technology & Vaccine Research Center, School of Public Health, Peking University, Beijing 100191, China., Liu Y; Department of Laboratorial Science and Technology & Vaccine Research Center, School of Public Health, Peking University, Beijing 100191, China., Cui F; Department of Laboratorial Science and Technology & Vaccine Research Center, School of Public Health, Peking University, Beijing 100191, China. |
| Source: | Vaccines [Vaccines (Basel)] 2021 Nov 29; Vol. 9 (12). Date of Electronic Publication: 2021 Nov 29. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X (Print) Linking ISSN: 2076393X NLM ISO Abbreviation: Vaccines (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2076-393X |
|---|---|
| DOI: | 10.3390/vaccines9121407 |
